Human chorionic gonadotropin promotes thyroid growth via thyrotropin receptors in FRTL-5 cells.
To ascertain the presence of thyroid growth-promoting activity (TGA) in the sera of pregnant women, we measured TGA in the sera of pregnant women by means of a bioassay based on [3H]-thymidine [( 3H]Tdr) incorporation in cultured rat FRTL-5 thyroid cells. Furthermore, to elucidate the mechanisms of human chorionic gonadotropin (hCG) in promoting the thyroid growth, we evaluated the effects of blocking type TSH receptor antibody (blocking IgGs) from patients with primary hypothyroidism on the activity of hCG. After the PEG-pretreated serum or the serum plus blocking IgGs was incubated for 72 h at 37 degrees C with FRTL-5 cells and [3H] Tdr, [3H] Tdr incorporated in the cells was counted. Although 9 normal pregnant women had normal TGA, two patients with hydatidiform mole, whose hCG levels were 966,500 and 497,100 IU/L, had positive TGA, but the activity showed normal when analyzed with the addition of a blocking IgG. hCG also showed a dose-dependent increase in [3H]Tdr incorporation, and it was inhibited by the addition of blocking IgGs. Furthermore, the inhibition of hCG-induced [3H]Tdr incorporation by 16 blocking IgGs correlated with their TBII and the inhibition activity of hCG-induced cAMP accumulation. Analysis by the Lineweaver-Burk plots of dose response curves of TSH- and hCG-induced [3H]Tdr incorporation showed the same inhibition pattern as with the addition of the same blocking IgGs. In conclusion, 1) hCG-related TGA exists in the sera of some patients with hydatidiform mole; and 2) hCG and the sera of some patients with hydatidiform mole promote thyroid growth, at least in a part, via TSH-receptors in FRTL-5 cells.
Yoshikawa
N
N
Second Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
Nishikawa
M
M
Horimoto
M
M
Yoshimura
M
M
Toyoda
N
N
Inada
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001681:Biological Assay; D003994:Bucladesine / Q000494:pharmacology; D002478:Cells, Cultured; D002772:Cholera Toxin / Q000494:pharmacology; D006063:Chorionic Gonadotropin / Q000494:pharmacology*; D005576:Colforsin / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D004247:DNA / Q000096:biosynthesis; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006828:Hydatidiform Mole / Q000378:metabolism; D007037:Hypothyroidism / Q000378:metabolism; D007074:Immunoglobulin G / Q000494:pharmacology; D066298:In Vitro Techniques; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000494:pharmacology; D011247:Pregnancy; D051381:Rats; D011989:Receptors, Thyrotropin / Q000187:drug effects*; D013961:Thyroid Gland / Q000187:drug effects* / Q000254:growth & development / Q000276:immunology; D013972:Thyrotropin / Q000378:metabolism / Q000494:pharmacology; D013974:Thyroxine / Q000378:metabolism
D006063:Chorionic Gonadotropin; D007074:Immunoglobulin G; D011989:Receptors, Thyrotropin; D005576:Colforsin; D011092:Polyethylene Glycols; D003994:Bucladesine; D013972:Thyrotropin; D004247:DNA; D002772:Cholera Toxin; D000242:Cyclic AMP; D013974:Thyroxine